1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin;Arch Ophthalmol,1999
2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin;Arch Ophthalmol,2001
3. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration;Am J Ophthalmol,2001
4. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP), Verteporfin in Photodynamic Therapy (VIP) Study Groups. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of two-year safety results in three randomized clinical trials—TAP and VIP report No. 4. Retina 2003. Forthcoming
5. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes;Retina,2002